🔥 Wednesday 27 May 2026 Wed, 27 May 2026

Xingye Gold (Hong Kong) Mining Company Limited has launched an off-market takeover offer for all remaining shares in Far East Gold Ltd (ASX:FEG) at $0.13 cash per share, offering shareholders a premium amid stalled projects and funding concerns.

Qoria Limited is moving towards a transformative merger with US-based Aura Consolidated Group, Inc., combining complementary digital safety platforms and targeting growth through a $100 million capital raise and ASX listing.

Klevo Rewards takes a major step in building a regulated crypto-financial platform by partnering with Bybit and proposing key acquisitions to expand Fly Wallet’s digital asset and credit capabilities.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

Cosmos Exploration has finalised its acquisition of EAU Lithium, issuing 108 million shares to former EAU shareholders and appointing James Durrant as Chairman to drive its Bolivian lithium ambitions.

Dicker Data has outperformed its FY25 guidance, delivering a 14.9% jump in gross revenue to $3.876 billion, fuelled by AI deals and infrastructure refreshes. The company’s FY26 outlook anticipates continued momentum in AI and data centre projects despite pricing pressures.

Classic Minerals has taken a decisive step towards mining at its Forrestania project by issuing a formal Notice of Decision to Commence Mining for the Lady Ada and Lady Magdalene deposits, despite ongoing legal challenges.

Metro Performance Glass has significantly improved its financial footing in FY26, cutting net debt by more than half and boosting EBITDA before significant items to $18.2 million despite subdued markets in New Zealand and Australia.

Lithium Energy nears completion of a major drilling campaign that reveals a substantial Exploration Target between its Burke and Mt Dromedary graphite deposits, while concurrently advancing the $20 million sale of its graphite assets.

Cauldron Energy has outlined a substantial new uranium exploration target on recently acquired tenements adjacent to Paladin’s Manyingee deposit, underpinning Yanrey’s growing status as a major uranium province in Western Australia.

Australian Gold and Copper Ltd (ASX: AGC) has secured the Junee Gold Project in NSW through a $5.4 million share deal, adding seven drill-ready gold targets and raising $5 million to accelerate exploration.

Australian Vintage Limited has locked in a $128 million refinancing deal extending to 2029 and reported a significant cash flow turnaround in FY26, driven by innovation and strategic acquisitions.

International Graphite Limited and Italian chemical producer Alkeemia have formalised a joint venture to develop a major graphite processing facility in Porto Marghera, Italy, targeting 15,000 tonnes per year by 2029 with first production expected in 2027.

Recce Pharmaceuticals has signed a non-binding term sheet with a major Middle Eastern pharma player for exclusive rights to commercialise its R327 Topical Gel across the MENA region, targeting a high diabetes burden market.

Element 25 has locked in Regroup Australia for long-term mining and ore haulage contracts, streamlining its Butcherbird Expansion Project supply chain and pushing towards a 1.1 Mtpa manganese output.

Bass Oil has landed a $3.5 million grant from the South Australian Government to fund a production pipeline for its 100% owned Kiwi gas project, aiming to connect it to Cooper Basin infrastructure and boost domestic gas supply by 2028.

Maronan Metals has completed a $22 million strategic placement with Kinterra Capital, which now holds nearly 20% of the company. The funds will accelerate an expanded 2026 drilling campaign and Preliminary Feasibility Study for the Maronan Project in Queensland.

Caprice Resources continues to expand its high-grade gold zones at the Island Gold Project with new significant intercepts confirming a multi-lode system beyond the main Vadrians lode.

Neurizon Therapeutics has boosted the participant count in its HEALEY ALS Platform Trial Regimen I from 160 to 240, capitalising on faster enrolment and philanthropic support to maintain costs and accelerate topline results to early Q3 2027.

Lithium Universe (ASX: LU7) has acquired exclusive global rights to a University of Edinburgh hydrometallurgical process that extracts gold and copper from electronic waste using recyclable organic compounds, positioning the company at the forefront of sustainable precious metals recovery.

Critica Limited’s Jupiter Rare Earth Project pilot plant has delivered a significant beneficiation breakthrough, upgrading feed to a ~3% TREO intermediate concentrate with strong magnet rare earth recoveries and substantial mass rejection.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.

Memphasys has landed a major 1,000-cartridge order for its Felix™ System from MENA distributor ITL, with strong repeat demand from Qatar’s Hamad Medical Corporation and new market expansions into UAE, Kuwait, and soon Turkey.

Redcastle Resources has launched continuous mining at its Redcastle Reef gold deposit, advancing from exploration to production under a capital-light joint venture with BML Ventures. Ore haulage to third-party processing is scheduled to begin in June 2026, with first toll treatment expected in July.